Clinical outcomes of patients with ulcerative colitis and co-existing clostridium difficile infection

Digestive Diseases and Sciences

Volumn 55, Issue 2, 2010, Pages 415-420

  Jodorkovsky, Daniela ^a   Young, Yuki ^a   Abreu, Maria T ^b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Clostridium difficile; Inflammatory bowel disease; Ulcerative colitis

Indexed keywords

CYCLOSPORIN; METRONIDAZOLE; VANCOMYCIN; ANTIINFECTIVE AGENT;

ADULT; ARTICLE; CLOSTRIDIUM DIFFICILE INFECTION; COHORT ANALYSIS; COLON RESECTION; FEMALE; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; ULCERATIVE COLITIS; CLOSTRIDIUM DIFFICILE; COMPARATIVE STUDY; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; FOLLOW UP; GASTROINTESTINAL ENDOSCOPY; HOSPITALIZATION; ISOLATION AND PURIFICATION; METHODOLOGY; PROGNOSIS; PSEUDOMEMBRANOUS COLITIS; RETROSPECTIVE STUDY; STATISTICS; TIME;

ADULT; ANTI-BACTERIAL AGENTS; CLOSTRIDIUM DIFFICILE; COLECTOMY; COLITIS, ULCERATIVE; DIAGNOSIS, DIFFERENTIAL; DISEASE PROGRESSION; ENDOSCOPY, GASTROINTESTINAL; ENTEROCOLITIS, PSEUDOMEMBRANOUS; FEMALE; FOLLOW-UP STUDIES; HOSPITALIZATION; HUMANS; MALE; PROGNOSIS; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 76849114352     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-009-0749-9     Document Type: Article

References (16)

1. L Archibald S Banerjee W Jarvis 2004 Secular trends in hospital-acquired Clostridium difficile disease in the United States, 1987-2001 J Infect Dis 189 1585 1589 10.1086/383045 10.1086/383045 15116293 (Pubitemid 38648285)
2. C Greenfield JR Aguilar Ramirez RE Pounder, et al. 1983 Clostridium difficile and inflammatory bowel disease Gut 24 8 713 717 10.1136/gut.24.8.713 10.1136/gut.24.8.713 1:STN:280:DyaL3s3mtlehuw%3D%3D 6135648
3. A Meyer R Nizar E Loftus, et al. 2004 The diagnostic yield of stool pathogen studies during relapses of inflammatory bowel disease J Clin Gastroenterol 38 9 772 775 10.1097/01.mcg.0000139057.05297.d6 10.1097/01.mcg.0000139057.05297.d6 15365403 (Pubitemid 39274178)
4. M Mylonaki L Langmead A Pantes, et al. 2004 Enteric infection in relapse of inflammatory bowel disease: importance of microbiological examination of stool Eur J Gastroenterol Hepatol 16 8 775 778 10.1097/01.meg.0000131040.38607. 09 10.1097/01.meg.0000131040.38607.09 15256979 (Pubitemid 39062569)
5. R Kochhar A Ayyagari MK Goenka, et al. 1993 Role of infectious agents in exacerbation of ulcerative colitis in India: a study of Clostridium difficile J Clin Gastroenterol 16 1 26 30 10.1097/00004836-199301000-00008 10.1097/00004836-199301000-00008 1:STN:280:DyaK3s7jt1alsA%3D%3D 8421140
6. YM Trnka JT LaMont 1981 Association of Clostridium difficile toxin with symptomatic relapse of chronic inflammatory bowel disease Gastroenterology 80 4 693 696 1:STN:280:DyaL3M7jvFCqsQ%3D%3D 7202941
7. P Weber M Koch WR Heizmann, et al. 1992 Microbic superinfection in relapse of inflammatory bowel disease J Clin Gastroenterol 14 4 302 308 10.1097/00004836-199206000-00008 10.1097/00004836-199206000-00008 1:STN:280:DyaK383pvF2gtw%3D%3D 1607606
8. J Rodemann E Dubberke K Reske, et al. 2007 Incidence of Clostridium difficile infection in inflammatory bowel disease Clin Gastroenterol Hepatol 5 3 339 344 10.1016/j.cgh.2006.12.027 10.1016/j.cgh.2006.12.027 17368233 (Pubitemid 46401530)
9. S Meyers L Mayer E Bottone, et al. 1981 Occurrence of Clostridium difficile toxin during the course of inflammatory bowel disease Gastroenterology 80 4 697 700 1:STN:280:DyaL3M7jvFCqtg%3D%3D 7202942
10. JT LaMont YM Trnka 1980 Therapeutic implications of Clostridium difficile toxin during relapse of chronic inflammatory bowel disease Lancet 1 8165 381 383 10.1016/S0140-6736(80)90939-3 10.1016/S0140-6736(80)90939-3 1:STN:280:DyaL3c7hvFGmsw%3D%3D 6101841
11. RP Bolton RJ Sherriff AE Read 1980 Clostridium difficile associated diarrhea: a role in inflammatory bowel disease? Lancet 1 8165 383 384 10.1016/S0140-6736(80)90940-X 10.1016/S0140-6736(80)90940-X 1:STN:280: DyaL3c7hvFGmsA%3D%3D 6101842
12. H Rüssmann K Panthel RC Bader, et al. 2007 Evaluation of three rapid assays for detection of Clostridium difficile toxin A and toxin B in stool specimens Eur J Clin Microbiol Infect Dis 26 2 115 119 10.1007/s10096-006-0251-7 10.1007/s10096-006-0251-7 17211606 (Pubitemid 46215301)
13. WE Aldeen M Bingham A Aiderzada, et al. 2000 Comparison of the TOX A/B test to a cell culture cytotoxicity assay for the detection of Clostridium difficile in stools Diagn Microbiol Infect Dis 36 4 211 213 10.1016/S0732- 8893(00)00113-9 10.1016/S0732-8893(00)00113-9 1:CAS:528:DC%2BD3cXitlOmtrs%3D 10764962 (Pubitemid 30179641)
14. CP Kelly C Pothoulakis JT LaMont 1994 Clostridium difficile colitis N Engl J Med 330 257 262 10.1056/NEJM199401273300406 10.1056/NEJM199401273300406 1:STN:280:DyaK2c%2FpsleksA%3D%3D 8043060 (Pubitemid 24034138)
15. Ananthakrishnan AN, McGinley EL, Binion DG. Excess hospitalization burden associated with Clostridium difficile in patients with Inflammatory Bowel Disease. Gut. 2007 [Epub ahead of print].
16. M Issa A Vijayapal MB Graham, et al. 2007 Impact of Clostridium difficile on inflammatory bowel disease Clin Gastroenterol Hepatol 5 3 345 351 10.1016/j.cgh.2006.12.028 10.1016/j.cgh.2006.12.028 17368234 (Pubitemid 46401531)